Clinical Trial Update: Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating the safety and efficacy of sequencing ponatinib followed by imatinib in patients with chronic-phase chronic myeloid le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Ponatinib (ponatinib)

Snippet

Sponsor: Centre Leon Berard | Conditions: Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING